跳至主要内容
临床试验/NCT06629207
NCT06629207招募中不适用

Artificial Intelligence on Molecular Imaging to Predict the Risks of Parkinson's Disease for Patients With Rapid Eye Movement Sleep Behavior Disorder

Insel Gruppe AG, University Hospital Bern2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2024年10月7日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
20
试验地点
2
主要终点
Assessment of Deep Learning Model Accuracy in Predicting Neurodegenerative Conversion in isolated REM sleep behavior disorder (iRBD) through Early Biomarker Detection

研究概览

简要总结

The study aims to systematically document the course of REM sleep behavior disorder (RBD) and investigate possible clinical and imaging biomarkers for disease progression and conversion risk to Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA). The study will use artificial intelligence to analyze imaging and develop a reliable method to predict and stratify patients approaching conversion to overt a-synucleinopathy. Participants will be clinically evaluated and 2 imaging procedures will be done.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Confirmed clinical iRBD diagnosis by movement disorder specialists according to the International Classification of Sleep Disorders
  • Written informed consent

排除标准

  • Known diagnosis of PD or other neurodegenerative disorder
  • Unequivocal signs of parkinsonism on examination
  • Narcolepsy or other known causes of RBD
  • Moderate to severe obstructive sleep apnea
  • Abnormal neurological or MRI examination

结局指标

主要结局

Assessment of Deep Learning Model Accuracy in Predicting Neurodegenerative Conversion in isolated REM sleep behavior disorder (iRBD) through Early Biomarker Detection

时间窗: From enrollment to end of follow-up period, expected to be 48 months

The investigators aim to evaluate the predictive accuracy of a deep learning model in identifying patients with iRBD who will progress to a neurodegenerative disorder. The primary outcome will assess the model's sensitivity in detecting early imaging biomarkers linked to disease progression, with the goal of enabling earlier intervention and improving long-term outcomes.

次要结局

  • Comparison of the Estimated versus Observed Annual Conversion Risk of Isolated Rapid Eye Movement Behavior Disorder (iRBD) to Neurodegenerative Disorders(From enrollment to end of follow-up period, expected to be 48 months)
  • Evaluation of Deep Learning Model Accuracy in Predicting Conversion of Isolated REM Sleep Behavior Disorder (iRBD) to Parkinson's Disease(From enrollment to end of follow-up period, expected to be 48 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Artificial Intelligence in Molecular Imaging:... | 临床试验